Stocks in Play

IntelGenx Corp.

09:42 AM EST - IntelGenx Corp. : Announced that Montelukast VersaFilm® has been administered to the first Parkinson’s Disease patients in the Phase 2 clinical trial. IntelGenx Corp. shares T.IGX are trading unchanged at $0.23.